U.S. Senate Hearing: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process (33/35)

< Prev Next >
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin (R) and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo look on  during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020.<br />
Credit: Andrew Caballero-Reynolds / Pool via CNP/AdMedia
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin (R) and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo look on during a United States Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, DC on June 2, 2020.
Credit: Andrew Caballero-Reynolds /...
more »

Filename: adm_060220_Finance-Drugs_CNP_018.jpg
Copyright
Date: 2 Jun 2020
Restrictions:
2003 - 2016 AdMedia Photo